← LifeMD, Inc. LFMD
Market Price
$3.45
Market Cap
$167.33M
P/E Ratio
13.80
Revenue (FY 2025)
↓-8.7% YoY
$194.06M
3-Yr CAGR: 17.7%
Net Income
↑176.0% YoY
$14.35M
Net Margin: 7.4%
Free Cash Flow
↓-60.0% YoY
$6.41M
FCF Yield: 3.83%
EPS (Diluted)
↑147.2% YoY
$0.25
Basic: $0.25
Return on Equity
Efficiency
62.0%
ROA: 20.4%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (LFMD)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $5.0M | — | $3.1M | $-1.1M | — | — | — | $-0.4M | — | — |
| FY 2017 | $5.0M | 0.0% | $3.5M | $-1.2M | -8.9% | $-0.03 | — | $-0.8M | — | — |
| FY 2018 | $0.0M | -99.1% | $6.4M | $-1.2M | -2.9% | $-0.02 | +33.3% | $-0.9M | — | — |
| FY 2019 | $12.5M | +29,227.5% | $9.2M | $-3.1M | -152.8% | $-0.32 | -1,500.0% | $0.3M | — | — |
| FY 2020 | $37.3M | +199.1% | $28.4M | $-58.6M | -1,769.4% | $-4.44 | -1,287.5% | $-12.1M | — | — |
| FY 2021 | $92.9M | +149.0% | $74.9M | $-60.9M | -3.8% | $-2.29 | +48.4% | $-33.1M | $-33.3M | — |
| FY 2022 | $119.0M | +28.2% | $100.4M | $-45.5M | +25.2% | $-1.57 | +31.4% | $-22.9M | $-23.3M | +30.1% |
| FY 2023 | $152.5M | +28.2% | $133.6M | $-20.6M | +54.8% | $-0.70 | +55.4% | $8.8M | $8.6M | +137.0% |
| FY 2024 | $212.5M | +39.3% | $188.4M | $-18.9M | +8.3% | $-0.53 | +24.3% | $17.5M | $16.0M | +86.0% |
| FY 2025 | $194.1M | -8.7% | $166.3M | $14.4M | +176.0% | $0.25 | +147.2% | $8.3M | $6.4M | -60.0% |
Valuation
Market Price
$3.45
Market Cap
$167.33M
Enterprise Value
N/A
P/E Ratio
13.80
P/B Ratio
7.21
FCF Yield
3.83%
Dividend Yield
64.31%
Shares Outstanding
Profitability & Margins
Gross Margin
85.72%
Operating Margin
3.95%
Net Margin
7.40%
Return on Equity (ROE)
61.99%
Return on Assets (ROA)
20.39%
Asset Turnover
2.76x
Revenue 3-Yr CAGR
17.69%
Financial Health & Liquidity
Current Ratio
3.24
Cash Ratio
2.30
Debt / Equity
N/A
Debt / Assets
N/A
Cash & Equivalents
$36.79M
Total Debt
N/A
Book Value / Share
$0.48
Cash Flow Efficiency
Operating Cash Flow
$8.28M
Capital Expenditures (CapEx)
$1.87M
Free Cash Flow
$6.41M
OCF / Revenue
4.27%
FCF / Revenue
3.30%
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
$0.25
EPS (Basic)
$0.25
Dividends / Share
$2.22
Book Value / Share
$0.48
EPS YoY Growth
147.17%
Balance Sheet (FY 2025)
Total Assets
$70.41M
Total Liabilities
$70.41M
Stockholders' Equity
$23.16M
Current Assets
$51.83M
Current Liabilities
$15.97M